Stakeholders in Tanzania’s health sector, particularly those involved in the manufacture of medicines and medical devices, are increasingly stepping forward to explore partnership and investment opportunities with the government, as the country intensifies efforts to ensure a reliable supply of quality health products.
This momentum was underscored during a meeting held in Dodoma on January 13, 2025, between the Minister for Health, Mr Mohamed Mchengerwa, and Mr Felix Ohnmacht, an executive from Access to Medicine (AXMED).
The discussions focused on strategies to mobilise financial resources that can accelerate investment in pharmaceutical and medical device industries in Tanzania.
Mr Mchengerwa said the government is committed to creating a supportive environment for investors in the health manufacturing sector.
He noted that AXMED had been advised to coordinate with the national committee tasked with fast-tracking and facilitating pharmaceutical investments, as well as with the Medical Stores Department, to streamline procedures and improve efficiency in the supply chain.
“The aim is to ensure sustainable access to essential medicines while strengthening local production capacity,” the minister said, adding that such partnerships are vital to improving healthcare delivery and reducing dependence on imports.
Mr Ohnmacht said AXMED has earmarked TZS 25 billion to boost access to essential medicines, with a particular focus on maternal and child health, across seven African countries.
He added that Tanzania is expected to benefit from TZS 5 billion, which will be used to procure health products aimed at improving treatment and preventive healthcare services.
In a related development, Mr Mchengerwa also held discussions with Ms Doris Mollel, Director of the Doris Mollel Foundation, who was accompanied by Mr Ohnmacht.
The talks focused on preparations for the launch of a neonatal ward scheduled for March 2, 2026, in Kwimba District, Mwanza Region.
Ms Mollel said the neonatal ward will be a major boost to maternal and newborn healthcare, particularly for premature babies.
She explained that the facility is expected to significantly reduce unnecessary referrals to Sekou-Toure and Bugando hospitals, saving time and resources while improving survival chances for newborns through timely access to specialised care.
The initiatives reflect the government’s broader strategy to strengthen Tanzania’s healthcare system through public-private partnerships, increased investment in local pharmaceutical manufacturing, and targeted interventions aimed at improving health outcomes for citizens.